B of A Securities:下调BioXcel Therapeutics(BTAI.US)评级,由买入调整至低于大市评级, 目标价由7.00美元调整至0.25美元。

金融界
08 Jan
B of A Securities:下调BioXcel Therapeutics(BTAI.US)评级,由买入调整至低于大市评级, 目标价由7.00美元调整至0.25美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10